Are Mpox Deaths Approaching 2,000 in Africa Since 2024 Amid Recent Declines?
Click to start listening
Synopsis
As mpox cases decline, Africa faces a grim milestone with deaths nearing 2,000 in 2024. What does this mean for public health in the region? The Africa CDC reports a significant drop in cases, but is it enough to ease the burden on healthcare systems?
Key Takeaways
- Mpox deaths in Africa are nearing 2,000.
- Recent trends show a decline in cases.
- Testing coverage has improved significantly.
- Public health emergency declared by Africa CDC.
- Infectious disease can cause severe symptoms.
Addis Ababa, Sep 5 (NationPress) The number of fatalities from Africa's ongoing mpox outbreak is nearing 2,000 since the start of 2024, even as there is a recent decline in case numbers, as reported by the Africa Centres for Disease Control and Prevention (Africa CDC).
In an online media briefing held on Thursday evening, Yap Boum II, the deputy incident manager for mpox at the Africa CDC, stated that 29 African countries affected by mpox have documented a total of 185,994 cases since the beginning of last year. Out of these, 51,969 were confirmed, leading to 1,987 reported fatalities.
According to data from the African Union's specialized healthcare agency, the continent has reported 105,697 mpox cases thus far in 2025, exceeding last year's total of 80,297.
With the enhancement of continental mpox response measures, the Africa CDC has observed a steady decline in both confirmed and suspected cases over the recent weeks, particularly when compared to the peak season recorded around May of this year.
Statistics from the Africa CDC reveal that the average weekly confirmed cases dropped by 52%, from a peak of 1,441 weekly average cases in May to 695 cases over the last five weeks.
The Africa CDC has also praised the increase in testing coverage as a significant advancement, with testing coverage rising from 30% to 66% among all suspected cases in the past six weeks.
Mpox, previously known as monkeypox, was first identified in laboratory monkeys in 1958. This rare viral disease is usually transmitted through body fluids, respiratory droplets, and contaminated materials. Symptoms often include fever, rash, and swollen lymph nodes, as reported by Xinhua news agency.
In August of last year, the Africa CDC classified the ongoing mpox outbreak as a public health emergency of continental security. Soon after, the World Health Organization declared the viral disease a public health emergency of international concern.
Mpox is an infectious disease that can lead to a painful rash, swollen lymph nodes, fever, headaches, muscle pain, back pain, and fatigue. While most individuals recover completely, some may experience severe illness.
Point of View
It's crucial to recognize that while the decline in mpox cases is positive, the nearing death toll of 2,000 should serve as a wake-up call for improved healthcare strategies in Africa. Our focus must remain on bolstering response efforts and increasing public awareness to prevent further loss.
NationPress
05/09/2025
Frequently Asked Questions
What is mpox?
Mpox, previously known as monkeypox, is a rare viral disease that spreads through body fluids and respiratory droplets, often resulting in fever and rash.
How many deaths have occurred due to mpox in Africa?
As of September 2024, mpox-related deaths in Africa have approached 2,000.
What measures are being taken to control mpox outbreaks?
The Africa CDC has reported a significant increase in testing coverage and is implementing strategies to reduce both confirmed and suspected cases.
What were the case numbers for mpox in 2025?
In 2025, Africa has reported 105,697 mpox cases to date, surpassing last year's total.
What symptoms are associated with mpox?
Symptoms of mpox include fever, rash, swollen lymph nodes, and general malaise.
